Trocoxil Back In Stock
9 years ago 
2176 views
Trocoxil, the only once monthly treatment for canine osteoarthritis, is back in stock following a supply shortage. Zoetis have been working hard to ensure improved supply on a number of brands including Apoquel, Palladia and now Trocoxil, with animal welfare being the key consideration at all times throughout this process.
Ned Flaxman, business unit director for companion animal, equine and innovation at Zoetis comments: “It was a really difficult decision to stop production of Trocoxil in favour of Apoquel and Palladia but we felt that it was the right thing to do on animal welfare grounds. As soon as we had full stocks of these products we resumed the manufacture of Trocoxil and I am delighted to say that it will be back in stock in December.
“I would like to thank our veterinary clients for their patience and reassure them that we brought the product back to market as quickly as we could and do not anticipate any further stock issues.”
Trocoxil chewable tablets are used for the treatment of pain and inflammation associated with degenerative joint disease in dogs aged 12 months or over.
For more information on Trocoxil please contact your Zoetis account manager.
More from Zoetis
- Vets encouraged to engage with their farmers on the importance of orf vaccination
- Zoetis Hosts Free Webinar to Share Latest Knowledge of Lungworm
- Vets Urge Action as Dog Arthritis Misconceptions Persist
- Zoetis Acquires Veterinary Pathology Group to Strengthen Veterinary Diagnostics in UK and Ireland
- Zoetis to Unveil End-to-End Support for Veterinary Care at London Vet Show 2025
4 days ago